175 related articles for article (PubMed ID: 35653194)
1. Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Zamler DB; Shingu T; Kahn LM; Huntoon K; Kassab C; Ott M; Tomczak K; Liu J; Li Y; Lai I; Zorilla-Veloz R; Yee C; Rai K; Kim BY; Watowich SS; Heimberger AB; Draetta GF; Hu J
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35653194
[TBL] [Abstract][Full Text] [Related]
2. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.
Rajendran S; Hu Y; Canella A; Peterson C; Gross A; Cam M; Nazzaro M; Haffey A; Serin-Harmanci A; Distefano R; Nigita G; Wang W; Kreatsoulas D; Li Z; Sepeda JA; Sas A; Hester ME; Miller KE; Elemento O; Roberts RD; Holland EC; Rao G; Mardis ER; Rajappa P
Cell Rep; 2023 Mar; 42(3):112197. PubMed ID: 36871221
[TBL] [Abstract][Full Text] [Related]
5. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
6. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
Front Immunol; 2022; 13():841404. PubMed ID: 35265085
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
Yeo AT; Rawal S; Delcuze B; Christofides A; Atayde A; Strauss L; Balaj L; Rogers VA; Uhlmann EJ; Varma H; Carter BS; Boussiotis VA; Charest A
Nat Immunol; 2022 Jun; 23(6):971-984. PubMed ID: 35624211
[TBL] [Abstract][Full Text] [Related]
8. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
9. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
10. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
11. Immune suppression in gliomas.
Grabowski MM; Sankey EW; Ryan KJ; Chongsathidkiet P; Lorrey SJ; Wilkinson DS; Fecci PE
J Neurooncol; 2021 Jan; 151(1):3-12. PubMed ID: 32542437
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Kong LY; Wu AS; Doucette T; Wei J; Priebe W; Fuller GN; Qiao W; Sawaya R; Rao G; Heimberger AB
Clin Cancer Res; 2010 Dec; 16(23):5722-33. PubMed ID: 20921210
[TBL] [Abstract][Full Text] [Related]
13. F11R is a novel monocyte prognostic biomarker for malignant glioma.
Pong WW; Walker J; Wylie T; Magrini V; Luo J; Emnett RJ; Choi J; Cooper ML; Griffith M; Griffith OL; Rubin JB; Fuller GN; Piwnica-Worms D; Feng X; Hambardzumyan D; DiPersio JF; Mardis ER; Gutmann DH
PLoS One; 2013; 8(10):e77571. PubMed ID: 24147027
[TBL] [Abstract][Full Text] [Related]
14. Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas.
Kanvinde PP; Malla AP; Connolly NP; Szulzewsky F; Anastasiadis P; Ames HM; Kim AJ; Winkles JA; Holland EC; Woodworth GF
Glia; 2021 Sep; 69(9):2059-2076. PubMed ID: 33638562
[TBL] [Abstract][Full Text] [Related]
15. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
16. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
17. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
[TBL] [Abstract][Full Text] [Related]
18. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.
Lin GL; Nagaraja S; Filbin MG; Suvà ML; Vogel H; Monje M
Acta Neuropathol Commun; 2018 Jun; 6(1):51. PubMed ID: 29954445
[TBL] [Abstract][Full Text] [Related]
19. The Role of Myeloid Cells in GBM Immunosuppression.
Lin YJ; Wu CY; Wu JY; Lim M
Front Immunol; 2022; 13():887781. PubMed ID: 35711434
[TBL] [Abstract][Full Text] [Related]
20. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
